Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking.

Developing new PI3Kγ inhibitors by combining pharmacophore modeling, molecular dynamic simulation, molecular docking, fragment-based drug design, and virtual screening.

A Transistor-Level DFF Based on FinFET Technology for Low Power Integrated Circuits.

Exploring PI3Kγ binding preference with Eganelisib, Duvelisib, and Idelalisib <i>via</i> energetic, pharmacophore and dissociation pathway analyses.

Discovery of potential inhibitors targeting the kinase domain of polynucleotide kinase/phosphatase (PNKP): Homology modeling, virtual screening based on multiple conformations, and molecular dynamics simulation.

The optimization of reverse logistics cost based on value flow analysis - a case study on automobile recycling company in China.